XPRT ANALYTICAL SERVICES Corporation

Call Directions Website Contact the business

XPRT ANALYTICAL SERVICES Corporation We are the XPRT ANALYTICAL SERVICES Corporation. “Providing Test Services Beyond Excellence”

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲!  💊𝐆𝐥𝐲𝐛𝐮𝐫𝐢𝐝𝐞 is an oral antidiabetic medication belonging to the sulfonylurea class. Also known as glibe...
13/11/2026

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 💊

𝐆𝐥𝐲𝐛𝐮𝐫𝐢𝐝𝐞 is an oral antidiabetic medication belonging to the sulfonylurea class. Also known as glibenclamide, it is used to help control blood glucose levels in adults with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin and is commonly used alongside proper diet and exercise to improve blood sugar control.

𝐇𝐨𝐰 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐰𝐨𝐫𝐤?
Glyburide works by binding to sulfonylurea receptors (SUR1) on pancreatic beta cells, which causes ATP-sensitive potassium channels to close. This leads to depolarization of the cell membrane, allowing calcium ions to enter the cells. The increased calcium concentration stimulates the release of insulin from the pancreas, helping lower blood glucose levels.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐩𝐨𝐬𝐬𝐢𝐛𝐥𝐞 𝐬𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬?
Glyburide may cause low blood sugar (hypoglycemia), which is one of its most important side effects. Symptoms may include sweating, shakiness, dizziness, headache, hunger, and weakness. Other possible effects include nausea, heartburn, stomach discomfort, weight gain, muscle or joint pain, blurred vision, and skin rashes. Serious reactions may include severe hypoglycemia, allergic reactions, liver problems, unusual bruising or bleeding, and seizures.

Interestingly, glyburide is also known as glibenclamide in many countries. Although it is an oral medication, its effect depends on the pancreas being able to produce insulin. This is why it is used for type 2 diabetes and is not suitable for treating type 1 diabetes, where the body produces little or no insulin.

𝗥𝗘𝗙𝗘𝗥𝗘𝗡𝗖𝗘𝗦
DrugBank. (n.d.). Glyburide. https://go.drugbank.com/drugs/DB01016

Mayo Clinic. (n.d.). Glyburide (oral route). https://www.mayoclinic.org/drugs-supplements/glyburide-oral-route/description/drg-20072094

RxList. (n.d.). Glyburide. https://www.rxlist.com/glyburide/generic-drug.htm

WebMD. (n.d.). Glyburide (Diabeta). https://www.webmd.com/drugs/glyburide-diabeta

Wolters Kluwer. (n.d.). Glyburide. Drugs.com. https://www.drugs.com/glyburide.html

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

🎉 𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲! 🎉𝐋𝐨𝐫𝐥𝐚𝐭𝐢𝐧𝐢𝐛 is a third-generation targeted pill specially engineered to shut down faulty cellular sign...
10/11/2026

🎉 𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲! 🎉

𝐋𝐨𝐫𝐥𝐚𝐭𝐢𝐧𝐢𝐛 is a third-generation targeted pill specially engineered to shut down faulty cellular signals in advanced non-small cell lung cancer (NSCLC). Designed to cross the blood-brain barrier, it hones in on abnormal ALK proteins to stop tumor expansion, providing a powerful option even when older targeted therapies have stopped working.

Unlike traditional non-specific chemotherapy, lorlatinib targets the hyperactive anaplastic lymphoma kinase (ALK) enzyme inside cancer cells. In ALK-positive tumors, this mutant enzyme acts as a master switch that continuously signals cells to divide and evade cell death. Lorlatinib selectively docks into this molecular switch, shutting down the cell's internal engine to halt tumor growth while sparing healthy surrounding tissue.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
𝐓𝐚𝐫𝐠𝐞𝐭 𝐁𝐢𝐧𝐝𝐢𝐧𝐠: Lorlatinib competitively binds to the ATP-binding pocket of the ALK tyrosine kinase domain, blocking the chemical energy supply required for enzyme activation.

𝐏𝐚𝐭𝐡𝐰𝐚𝐲 𝐈𝐧𝐭𝐞𝐫𝐫𝐮𝐩𝐭𝐢𝐨𝐧: This prevents ALK autophosphorylation and inhibits downstream signaling cascades—specifically the MAPK and PI3K/AKT/mTOR pathways that are crucial for cancer cell survival, proliferation, and growth.

𝐓𝐮𝐦𝐨𝐫 𝐄𝐥𝐢𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧: By successfully cutting off these essential growth signals, lorlatinib induces apoptosis (programmed cell death) in ALK-driven tumor cells while overcoming key treatment-resistant mutations.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Common side effects of lorlatinib include swelling (edema), weight gain, numbness (peripheral neuropathy), fatigue, mood changes, and joint or muscle pain.

𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭
Lorlatinib should be taken exactly as prescribed by your oncologist, once daily with or without food. Inform your doctor immediately if you experience severe breathlessness, sudden changes in mood or memory, or chest pain.

✨ A Moment of Reflection ✨
🌿 "He sent out his word and healed them; he rescued them from the grave." — Psalm 107:20

𝐑𝐄𝐅𝐄𝐑𝐄𝐍𝐂𝐄𝐒
[1] BenchChem. Lorlatinib's Mechanism of Action Against ALK Mutations: A Technical Guide.https://pdf.benchchem.com/560/Lorlatinib_s_Mechanism_of_Action_Against_ALK_Mutations_A_Technical_Guide.pdf

[2] DrugBank. Lorlatinib profile (DB12130). https://go.drugbank.com/drugs/DB12130

[3] Drugs.com. Lorlatinib side effects & oral medical information. https://www.drugs.com/sfx/lorlatinib-side-effects.html

[4] National Center for Biotechnology Information (2026). PubChem Compound Summary for CID 71731823, Lorlatinib. Retrieved November 9, 2026 from https://pubchem.ncbi.nlm.nih.gov/compound/Lorlatinib

XPRT Analytical Services Corporation is one of the leading analytical laboratory services companies providing advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

🎉 𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 🎉​𝐎𝐬𝐢𝐦𝐞𝐫𝐭𝐢𝐧𝐢𝐛 is a third-generation targeted therapy prescribed for non-small cell lung cancer (NSCLC...
06/11/2026

🎉 𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 🎉
​
𝐎𝐬𝐢𝐦𝐞𝐫𝐭𝐢𝐧𝐢𝐛 is a third-generation targeted therapy prescribed for non-small cell lung cancer (NSCLC) harboring specific genetic mutations. Unlike standard chemotherapy, which affects both sick and healthy cells, osimertinib is a precision-engineered pill designed to target cancer proteins directly while sparing healthy tissue. It is especially vital for patients whose tumors have stopped responding to older targeted treatments, offering a more effective, low-toxicity way to manage advanced disease.

​Rather than acting non-specifically, osimertinib focuses on specific flaws in the cell's growth signaling pathway. Inside the cell, it targets the microscopic "on switches" (epidermal growth factor receptors, or EGFR) that fuel tumor growth. By interrupting this energy supply, it halts the expansion of cancer cells while keeping healthy surrounding tissues safe.

​𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
​𝐓𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠: Inside the cell, osimertinib targets the epidermal growth factor receptors (EGFR) that drive lung cancer cell growth.

​𝐄𝐧𝐳𝐲𝐦𝐞 𝐁𝐥𝐨𝐜𝐤: It permanently locks onto the ATP-binding site of mutated proteins—specifically targeting the 𝒆𝒙𝒐𝒏 𝟏𝟗 𝒅𝒆𝒍𝒆𝒕𝒊𝒐𝒏, 𝑳𝟖𝟓𝟖𝑹, and 𝑻𝟕𝟗𝟎𝑴 resistance mutations—blocking the chemical energy the cancer needs to multiply.

​𝐒𝐞𝐥𝐞𝐜𝐭𝐢𝐯𝐞 𝐄𝐥𝐢𝐦𝐢𝐧𝐚𝐭𝐢𝐨𝐧: With an affinity for mutant structures up to 200 times higher than for normal receptors, it shuts down tumor signaling pathways while sparing healthy tissue to minimize toxicity.

​𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Common side effects of osimertinib include diarrhea, skin rash, dry skin, nail changes (paronychia), fatigue, mouth sores, cough, and temporary changes in blood cell counts.

​𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭
Osimertinib should be taken exactly as prescribed by your oncologist, once daily with or without food. Inform your doctor immediately if you experience severe breathlessness or chest pain.

​✨ A Moment of Reflection ✨
🌿 "He heals the brokenhearted and binds up their wounds." — Psalm 147:3

​𝐑𝐄𝐅𝐄𝐑𝐄𝐍𝐂𝐄𝐒
[1] DrugBank. Osimertinib profile (DB09330). https://go.drugbank.com/drugs/DB09330

​[2] National Center for Biotechnology Information (2026). PubChem Compound Summary for CID 71496458, Osimertinib. https://pubchem.ncbi.nlm.nih.gov/compound/Osimertinib

​[3] WebMD. Osimertinib oral medical information & side effects. https://www.webmd.com/drugs/2/drug-170308/osimertinib-oral/details

​XPRT Analytical Services Corporation is one of the leading analytical laboratory services companies providing advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

​If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

​

𝐗𝐏𝐑𝐓 𝐀𝐍𝐀𝐋𝐘𝐓𝐈𝐂𝐀𝐋 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧 joins the global community in observing Lung Cancer Awareness Month, raising awaren...
04/11/2026

𝐗𝐏𝐑𝐓 𝐀𝐍𝐀𝐋𝐘𝐓𝐈𝐂𝐀𝐋 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐢𝐨𝐧 joins the global community in observing Lung Cancer Awareness Month, raising awareness about lung cancer, its risk factors, the importance of prevention, and the value of early detection. This month, we highlight the importance of understanding lung cancer, recognizing potential warning signs, and encouraging individuals to take proactive steps toward protecting their respiratory health.

𝐋𝐮𝐧𝐠 𝐜𝐚𝐧𝐜𝐞𝐫 remains one of the leading public health challenges worldwide. According to the International Agency for Research on Cancer (IARC), approximately 2.6 million people were diagnosed with lung cancer and around 1.9 million died from the disease in 2024. Although to***co smoking remains its most common cause, lung cancer can also develop due to exposure to second-hand smoke, air pollution, diesel engine exhaust, asbestos, and other occupational hazards. Importantly, lung cancer does not affect smokers alone, as people who have never smoked can also develop the disease.

Recognizing possible warning signs is an important step toward timely medical attention. Common symptoms may include a persistent or worsening cough, chest pain, shortness of breath, coughing up blood, unexplained weight loss, and recurring respiratory infections. However, these symptoms may also be associated with other conditions. Consulting a qualified healthcare professional is essential for proper evaluation and diagnosis.

𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐞𝐚𝐫𝐥𝐲 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐦𝐚𝐤𝐞 𝐚 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞. Avoiding to***co, quitting smoking, limiting exposure to second-hand smoke, and reducing contact with harmful environmental and workplace substances are important ways to lower lung cancer risk. Individuals with a history of smoking or other significant risk factors should consult their healthcare providers to determine whether lung cancer screening is appropriate.

Together, we can help build a community that understands the risks of lung cancer, supports healthier choices, and encourages people to seek medical attention without delay. Through education, prevention, research, and access to appropriate healthcare, we can contribute to better outcomes and improved quality of life for individuals and families affected by lung cancer.

𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬:

International Agency for Research on Cancer. (2026, November 2). Lung Cancer Awareness Month 2026. IARC. https://www.iarc.who.int/news-events/lung-cancer-awareness-month-2026/

World Health Organization. (2026, April 16). Lung cancer. WHO. https://www.who.int/news-room/fact-sheets/detail/lung-cancer

International Agency for Research on Cancer. (n.d.). Lung cancer. IARC. https://www.iarc.who.int/cancer-type/lung-cancer/

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater to the cosmetic, veterinary, and other industries alike.

If you need more information about our services or have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲!  💊𝐃𝐞𝐮𝐜𝐫𝐚𝐯𝐚𝐜𝐢𝐭𝐢𝐧𝐢𝐛 is an oral medication used to treat adults with moderate-to-severe plaque psoriasis w...
30/10/2026

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 💊

𝐃𝐞𝐮𝐜𝐫𝐚𝐯𝐚𝐜𝐢𝐭𝐢𝐧𝐢𝐛 is an oral medication used to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It selectively inhibits tyrosine kinase 2 (TYK2), a protein involved in inflammatory signaling pathways regulated by interleukin-12 (IL-12), interleukin-23 (IL-23), and type I interferons. By suppressing these pathways, deucravacitinib helps reduce skin inflammation and psoriasis symptoms.

Its once-daily oral administration offers a convenient treatment option. Compared with apremilast and other systemic treatments, its efficacy and safety profile have been evaluated in clinical studies, although individual outcomes may vary.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
Deucravacitinib selectively inhibits tyrosine kinase 2 (TYK2), an enzyme in the Janus kinase (JAK) family responsible for activating the JAK–STAT signaling pathway. TYK2 regulates inflammatory responses mediated by interleukin-12 (IL-12), interleukin-23 (IL-23), and type I interferons. In psoriasis, IL-23 stimulates T-helper 17 (Th17) cells to produce inflammatory mediators, including IL-17 and tumor necrosis factor-alpha (TNF-α), which contribute to skin inflammation and excessive epidermal cell growth.

Deucravacitinib binds allosterically to the regulatory pseudokinase (JH2) domain of TYK2, inducing a conformational change that keeps the enzyme inactive. In laboratory studies, it demonstrated approximately 100- to 2,000-fold greater selectivity for TYK2 than for JAK1, JAK2, and JAK3, with minimal binding to these other enzymes. This selective inhibition reduces inflammatory signaling and the expression of psoriasis-associated genes, including those involved in the IL-23 and type I interferon pathways.

After 16 weeks of once-daily treatment, reductions in inflammatory markers such as IL-17A, IL-19, and beta-defensin were observed in patients with psoriasis. However, the precise relationship between these molecular changes and the drug's clinical effects remains incompletely understood.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬 💊
Deucravacitinib may cause several unwanted effects, including headache, fever, chills, cough, sore throat, sneezing, nasal congestion, and a runny nose. Other possible symptoms include muscle aches, body pain, fatigue, swollen glands, voice changes, and discomfort around the eyes and cheekbones.

These effects may vary among individuals and may be associated with infections, such as upper respiratory tract infections. Patients should monitor their symptoms and consult a healthcare professional if they persist or worsen. Chest tightness, difficulty breathing, or trouble swallowing require immediate medical attention, as these may indicate a serious reaction.

𝗣𝗿𝗲𝗰𝗮𝘂𝘁𝗶𝗼𝗻𝘀 ⚠
Patients taking deucravacitinib should attend regular medical checkups and undergo recommended blood tests to monitor their progress and detect potential adverse effects. Because the medication affects immune signaling, patients should promptly report signs of infection, including fever, chills, cough, or unusual fatigue. Tuberculosis screening is required before treatment, and symptoms of herpes infections, severe allergic reactions, or unusual swelling should be evaluated immediately.

Patients should also seek medical attention for warning signs such as unexplained weight loss, swollen glands, dark urine, severe muscle pain, chest pain, or difficulty breathing. Before receiving any vaccine, patients should consult their doctor and avoid live vaccines during treatment.

𝐓𝐚𝐤𝐞 𝐍𝐨𝐭𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐔𝐬𝐢𝐧𝐠 𝐭𝐡𝐞 𝐃𝐞𝐮𝐜𝐫𝐚𝐯𝐚𝐜𝐢𝐭𝐢𝐧𝐢𝐛‼️
Before using deucravacitinib, patients should inform their doctor of any known allergies to medications or substances such as foods, dyes, and preservatives to help prevent possible allergic reactions. The safety and effectiveness of the medication in children have not been established due to limited research. In older adults, deucravacitinib may be used with caution, as they may be more susceptible to serious infections and require closer monitoring.

For breastfeeding mothers, insufficient evidence is available regarding the medication’s safety for infants; therefore, consultation with a healthcare professional is necessary to weigh the potential benefits of treatment against the possible risks.

𝗥𝗘𝗙𝗘𝗥𝗘𝗡𝗖𝗘𝗦
DrugBank. (n.d.). Deucravacitinib: Uses, interactions, mechanism of action. https://go.drugbank.com/drugs/DB16650

Hoy, S. M. (2022). Deucravacitinib: First approval. Drugs, 82(17), 1671–1679. https://doi.org/10.1007/s40265-022-01796-y

Kalola, U. K., Alberty, A., & Sheehy, C. (2024). Deucravacitinib. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK606109/

Mayo Clinic. (2026, August 1). Deucravacitinib (oral route). https://www.mayoclinic.org/drugs-supplements/deucravacitinib-oral-route/description/drg-20538853

The Every Day Pill for Everyday Life - SOTYKTU® (deucravacitinib). (n.d.). https://www.sotyktu.com/

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲!💊Dimercaprol is a medication classified as a chelating agent that is used to treat poisoning caused by ce...
27/10/2026

𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲!💊

Dimercaprol is a medication classified as a chelating agent that is used to treat poisoning caused by certain heavy metals, such as arsenic, mercury, and gold. It may also be used in combination with calcium disodium EDTA to treat severe lead poisoning. Dimercaprol was originally developed during World War II as an antidote to lewisite, an arsenic-containing chemical warfare agent. It is administered through deep intramuscular injection because it is not suitable for oral administration.

How Does It Work?
Dimercaprol works by binding to toxic heavy metals through its two sulfhydryl (–SH) groups. These groups form stable complexes with certain metals, preventing them from interacting with important enzymes and interfering with normal cellular functions. The resulting complexes can then be eliminated from the body, primarily through the kidneys in urine. By reducing the harmful effects of heavy metals, dimercaprol helps protect tissues and organs from further damage. It is generally more effective when administered soon after exposure, before the metals cause extensive damage to the body's enzymes.

Common Side Effects
Dimercaprol may cause several side effects, and their severity can depend on the dose and frequency of administration. These include:
- Nausea and vomiting
- Increased blood pressure (hypertension)
- Rapid heartbeat (tachycardia)
- Headache and dizziness
- Abdominal pain
- Fever and sweating
- Muscle pain and weakness
- Burning or tingling sensations
- Excessive tearing and salivation

In some cases, serious reactions, including seizures, confusion, or loss of consciousness, may occur. Dimercaprol therefore requires careful medical supervision. It is also formulated in peanut oil, making it unsuitable for patients with a peanut allergy.

References:
https://www.ncbi.nlm.nih.gov/books/NBK549804
https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/dimercaprol
https://go.drugbank.com/drugs/DB06782

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 🎉​𝐍𝐢𝐭𝒂𝐳𝐨𝐱𝒂𝐧𝐢𝐝𝐞 is a broad-spectrum oral antiparasitic medication primarily prescribed to treat intestin...
23/10/2026

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲! 🎉
​
𝐍𝐢𝐭𝒂𝐳𝐨𝐱𝒂𝐧𝐢𝐝𝐞 is a broad-spectrum oral antiparasitic medication primarily prescribed to treat intestinal infections caused by single-celled protozoa, such as 𝑮𝒊𝒂𝒓𝒅𝒊𝒂 𝒍𝒂𝒎𝒃𝒍𝒊𝒂 and 𝑪𝒓𝒚𝒑𝒕𝒐𝒔𝒑𝒐𝒓𝒊𝒅𝒊𝒖𝒎 𝒑𝒂𝒓𝒗𝒖𝒎. These microscopic parasites are frequently transmitted through contaminated water and food, causing gastrointestinal conditions such as traveler's diarrhea. Nitazoxanide helps inhibit these harmful parasites, relieving distressing symptoms such as severe diarrhea, stomach pain, and abdominal cramps.

​Rather than acting as a traditional antibiotic, nitazoxanide targets specific metabolic pathways crucial to the survival of anaerobic organisms. Upon administration, it works by shutting down the parasite's internal energy production, stopping its growth and allowing the body's immune system to safely flush the infection out. Nitazoxanide is approved for use in both adults and pediatric patients aged 1 year and older.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
​𝐀𝐜𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧: Once ingested, nitazoxanide is rapidly metabolized in the body into its active metabolite, 𝒕𝒊𝒛𝒐𝒙𝒂𝒏𝒊𝒅𝒆.

​𝑬𝒏𝒛𝒚𝒎𝒆 𝑩𝒍𝒐𝒄𝒌: It blocks the 𝒑𝒚𝒓𝒖𝒗𝒂𝒕𝒆:𝒇𝒆𝒓𝒓𝒆𝒅𝒐𝒙𝒊𝒏 𝒐𝒙𝒊𝒅𝒐𝒓𝒆𝒅𝒖𝒄𝒕𝒂𝒔𝒆 (𝑷𝑭𝑶𝑹) enzyme-dependent electron transfer reaction, shutting down essential anaerobic energy metabolism in the parasite.

​𝑬𝒍𝒊𝒎𝒊𝒏𝒂𝒕𝒊𝒐𝒏: Deprived of cellular energy, growth of 𝑮𝒊𝒂𝒓𝒅𝒊𝒂 and 𝑪𝒓𝒚𝒑𝒕𝒐𝒔𝒑𝒐𝒓𝒊𝒅𝒊𝒖𝒎 is inhibited, allowing the host immune system to successfully clear the infection.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Common side effects of nitazoxanide are generally mild and may include abdominal pain, nausea, headache, and temporary, harmless urine discoloration.

𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭
Nitazoxanide should be taken with food to maximize absorption. Always complete the full course of treatment as prescribed by a medical professional.

​✨ A Moment of Reflection ✨
🌿 "For I will restore health to you, and your wounds I will heal, declares the Lord." — Jeremiah 30:17

𝐑𝐄𝐅𝐄𝐑𝐄𝐍𝐂𝐄𝐒
[1] DrugBank. Nitazoxanide profile (DB00507). https://go.drugbank.com/drugs/DB00507

​[2] Drugs.com. Nitazoxanide medical information & side effects. https://www.drugs.com/mtm/nitazoxanide.html

​[3] Medicine.com. Nitazoxanide prescribing & HCP guide. https://www.medicine.com/drug/nitazoxanide/hcp

​[4] National Center for Biotechnology Information. PubChem Compound Summary for CID 41684, Nitazoxanide. https://pubchem.ncbi.nlm.nih.gov/compound/Nitazoxanide

XPRT Analytical Services Corporation is one of the leading analytical laboratory services companies providing advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

​

𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲! 💊𝑻𝒂𝒇𝒍𝒖𝒑𝒓𝒐𝒔𝒕 is a prostaglandin analogue used to lower intraocular pressure (IOP) in patients with open-a...
20/10/2026

𝐓𝐫𝐢𝐯𝐢𝐚 𝐓𝐮𝐞𝐬𝐝𝐚𝐲! 💊

𝑻𝒂𝒇𝒍𝒖𝒑𝒓𝒐𝒔𝒕 is a prostaglandin analogue used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It works by mimicking the effects of prostaglandin F2α-related compounds and activating prostanoid receptors in the eye, which increases the outflow of aqueous humor through the uveoscleral pathway. Aqueous humor is the clear fluid that nourishes the eye and maintains its shape. By improving fluid drainage, tafluprost helps prevent excessive pressure buildup that can damage the optic nerve and lead to progressive vision loss.

After administration, tafluprost is converted into its active metabolite, tafluprost acid, which produces its pressure-lowering effect. It is commonly administered as eye drops once daily in the evening, as prescribed by a healthcare professional. Regular use and eye examinations are important to monitor treatment effectiveness and potential side effects, such as eye redness, eyelash growth, and gradual darkening of iris pigmentation.

𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺 𝗼𝗳 𝗔𝗰𝘁𝗶𝗼𝗻 💊
Tafluprost is a fluorinated analogue of prostaglandin F2α (PGF2α) and a potent, selective agonist of the FP prostanoid receptor. It is used as an ophthalmic medication to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Tafluprost acts as a prodrug, meaning it is converted into its biologically active metabolite, tafluprost acid, after penetrating the cornea. This active metabolite stimulates FP receptors in the eye, promoting the outflow of aqueous humor through the uveoscleral pathway. Aqueous humor is the clear fluid that nourishes the eye and helps maintain its internal pressure. By increasing fluid drainage, tafluprost helps lower IOP and reduce the risk of optic nerve damage associated with glaucoma. Although its pressure-lowering effect is established, the exact cellular mechanism responsible for increasing uveoscleral outflow has not been fully elucidated.

𝗖𝗼𝗺𝗺𝗼𝗻 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁𝘀
Tafluprost eye drops may cause several side effects, particularly involving the eyes. Eye redness (conjunctival 𝒉𝒚𝒑𝒆𝒓𝒆𝒎𝒊𝒂) is one of the most commonly reported effects and occurs when blood vessels on the eye's surface become more visible. Other possible effects include cataract formation, blurred vision, and headache. Some patients may also experience respiratory symptoms, such as a stuffy nose, cough, or sore throat, as well as a urinary tract infection (UTI). In clinical studies, headache, cough, common cold, and UTI were reported in some patients using tafluprost, although these effects do not necessarily occur in everyone or prove that the medication caused them. Patients should consult a healthcare professional if side effects persist or worsen, and seek prompt medical attention for sudden vision changes, significant eye pain, or swelling.

𝗣𝗿𝗲𝗰𝗮𝘂𝘁𝗶𝗼𝗻𝘀 ⚠
Regular visits to an ophthalmologist are essential while using tafluprost to monitor treatment effectiveness and identify possible adverse effects. The medication may gradually cause increased iris pigmentation, making the treated eye appear darker over several months or years. It may also cause eyelashes to become longer, thicker, or more prominent, with these changes generally limited to the treated eye and potentially reversible after discontinuation. Additionally, symptoms such as itching, redness, swelling, or irritation of the eyes or eyelids may indicate an allergic reaction and should be reported to a healthcare professional. Patients should consult their ophthalmologist if they notice unusual changes or have concerns during treatment.

𝗥𝗘𝗙𝗘𝗥𝗘𝗡𝗖𝗘𝗦
Mayo Clinic. (n.d.). Tafluprost (ophthalmic route). https://www.mayoclinic.org/drugs-supplements/tafluprost-ophthalmic-route/description/drg-20075545

National Center for Biotechnology Information (2026). PubChem Compound Summary for CID 125463293, Tafluprost Impurity 6. Retrieved October 17, 2026 from Chemical Structure. https://pubchem.ncbi.nlm.nih.gov/compound/Tafluprost-Impurity-6

Ohashi, M., & colleagues. (2010). Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension. Clinical Ophthalmology, 4, 163–170. https://pmc.ncbi.nlm.nih.gov/articles/PMC2850830/

U.S. National Library of Medicine. (2026). Tafluprost ophthalmic solution: Drug label information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaab8b3-3791-49ba-909e-a09651a30b33

U.S. National Library of Medicine. (n.d.). Tafluprost ophthalmic solution: Prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bfffa484-4105-45ec-ab1d-124e96639f35

U.S. National Library of Medicine. (n.d.). Tafluprost ophthalmic. MedlinePlus. https://medlineplus.gov/druginfo/meds/a612030.html

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲!🎉𝐕𝐢𝐥𝐨𝐱𝐚𝐳𝐢𝐧𝐞 is a prescription medication classified as a selective norepinephrine reuptake inhibitor (NR...
16/10/2026

𝐅𝐮𝐧 𝐅𝐚𝐜𝐭 𝐅𝐫𝐢𝐝𝐚𝐲!🎉

𝐕𝐢𝐥𝐨𝐱𝐚𝐳𝐢𝐧𝐞 is a prescription medication classified as a selective norepinephrine reuptake inhibitor (NRI). It is available in an extended-release oral formulation and is approved for the treatment of ADHD in children aged 6 years and older, adolescents, and adults. It is intended to help manage symptoms that may affect attention, behavior, and everyday activities.

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦 𝐨𝐟 𝐀𝐜𝐭𝐢𝐨𝐧
Viloxazine primarily inhibits the reuptake of norepinephrine, a neurotransmitter that plays an important role in attention, alertness, and impulse control. It may also influence serotonin signaling in the brain. However, its exact mechanism of action in treating ADHD is not yet fully understood.

Norepinephrine helps regulate communication between nerve cells and supports brain functions involved in concentration and behavioral control. By affecting norepinephrine and serotonin signaling, viloxazine may influence neural processes associated with ADHD symptoms. Further research is still needed to fully understand how these effects contribute to its therapeutic benefits.

𝐇𝐨𝐰 𝐈𝐭 𝐖𝐨𝐫𝐤𝐬
By increasing the availability of norepinephrine in the brain, viloxazine may help regulate processes associated with attention, alertness, and behavioral control. Norepinephrine plays an important role in brain functions related to concentration and impulse regulation, which are often affected in individuals with ADHD. Through its effects on neurotransmitter signaling, viloxazine may help improve focus, manage impulsive behaviors, and support daily functioning. However, its exact therapeutic mechanism in ADHD is not yet fully understood, and treatment responses may vary from person to person. Regular follow-up with a healthcare professional is important to monitor treatment effectiveness, side effects, and overall progress.

𝐂𝐨𝐦𝐦𝐨𝐧 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬
Common side effects of viloxazine include decreased appetite, nausea, vomiting, stomach pain, fatigue, drowsiness, irritability, and insomnia or difficulty sleeping. Not everyone experiences these effects, and their severity may differ from person to person. Consult a healthcare professional if side effects persist, worsen, or interfere with daily activities.

𝐒𝐚𝐟𝐞𝐭𝐲 𝐑𝐞𝐦𝐢𝐧𝐝𝐞𝐫⚠
Viloxazine should be taken only as prescribed by a qualified healthcare professional, and patients should follow the recommended dosage instructions carefully. Inform your healthcare provider about other medications or supplements you are taking to help prevent potentially harmful drug interactions. Patients and caregivers should also monitor for unusual mood or behavioral changes, including suicidal thoughts or behaviors, and seek immediate medical assistance if these occur.

Reference:
[1] Haddad, H. W., Hankey, P. B., Ko, J., Eswani, Z., Bhatti, P., Edinoff, A. N., Kaye, A. M., & Kaye, A. D. (2022). Viloxazine, a non-stimulant norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder: A 3 year update. Health Psychology Research, 10(3), 37018. https://doi.org/10.52965/001c.37018

[2] Viloxazine. (n.d.). Go.Drugbank.Com. Retrieved October 15, 2026, from https://go.drugbank.com/drugs/DB09185

[3] Viloxazine (oral route) description and brand names - mayo clinic. (n.d.). Www.Mayoclinic.Org. Retrieved October 15, 2026, from https://www.mayoclinic.org/drugs-supplements/viloxazine-oral-route/description/drg-20512960

[4] Viloxazine oral extended-release capsules. (2023, September 20). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/23842-viloxazine-extended-release-capsules

Image from:
[5] National Center for Biotechnology Information (2026). PubChem Compound Summary for CID 5666, Viloxazine. Retrieved October 14, 2026 from https://pubchem.ncbi.nlm.nih.gov/compound/Viloxazine

XPRT is one of the leading analytical laboratory services companies that provide advanced testing and analytical services to a wide range of healthcare industries, such as drug manufacturers, distributors, importers, hospitals, and drug stores. We also cater these services to cosmetic, veterinary, and other industries alike.

If you need more information about our services or if you have any inquiries, you may reach out to us via email at [email protected] or contact us at (02) 8551-3422 loc. 132.

Address

3759 Skrene Properties Bldg. , Cuenca Cor. Emilia Street , Palanan, Makati City
Makati
1235

Opening Hours

Monday 7am - 3pm
Tuesday 7am - 3pm
Wednesday 7am - 3pm
Thursday 7am - 3pm
Friday 7am - 3pm

Telephone

+6325513422

Alerts

Be the first to know and let us send you an email when XPRT ANALYTICAL SERVICES Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to XPRT ANALYTICAL SERVICES Corporation:

Shortcuts

Share

Nearby health & beauty businesses